Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 65 citing Mittelman: Extreme insulin resistance of the central adipose depot in vivo. (0.11 sec) 

Abdominal obesity and metabolic syndrome

- biosino.org [PDF] 
JP Després, I Lemieux - NATURE-LONDON-, 2006 - Springer
Despite the fact that the obesity epidemic has received intense media cover-
age, many physicians still fail to recognize that the rapidly growing prevalence
of type 2 diabetes in their practice is the result of our “toxic” ...
Cited by 424 - Related articles - BL Direct - All 9 versions

Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-{ …

- diabetesjournals.org
G Boden, P She, M Mozzoli, P Cheung, K … - Diabetes, 2005 - Am Diabetes Assoc
To study mechanisms by which free fatty acids (FFAs) cause hepatic insulin
resistance, we have used euglycemic-hyperinsulinemic clamping with and without
infusion of lipid/heparin (to raise or to lower plasma FFAs) in alert male ...
Cited by 147 - Related articles - BL Direct - All 6 versions

Molecular evidence supporting the portal theory: a causative link between visceral adiposity …

- physiology.org
M Kabir, KJ Catalano, S Ananthnarayan, SP … - American Journal of Physiology- Endocrinology And …, 2005 - Am Physiological Soc
The mechanism by which increased central adiposity causes hepatic insulin
resistance is unclear. The "portal hypothesis" implicates increased lipolytic
activity in the visceral fat and therefore increased delivery of free fatty ...
Cited by 81 - Related articles - All 4 versions

Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced …

- diabetesjournals.org
SP Kim, M Ellmerer, GW Van Citters, RN … - Diabetes, 2003 - Am Diabetes Assoc
Obesity is highly correlated with insulin resistance and the development of type
2 diabetes. Insulin resistance will result in a decrease in insulin's ability to
stimulate glucose uptake into peripheral tissue and will suppress glucose ...
Cited by 78 - Related articles - BL Direct - All 4 versions

The sympathetic nervous system and the metabolic syndrome

- nursing2008.com
G Mancia, P Bousquet, JL Elghozi, M Esler, G … - Journal of hypertension, 2007 - journals.lww.com
Page 1. Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction
of this article is prohibited. The sympathetic nervous ...
Cited by 79 - Related articles - BL Direct - All 8 versions

Longitudinal changes in insulin sensitivity and secretion from birth to age three years in …


V Mericq, KK Ong, R Bazaes, V Pena, A Avila, … - Diabetologia, 2005 - Springer
Abstract Aims/hypothesis: Insulin resistance and type 2 dia- betesriskin human
subjects who were small-for-gestational- age (SGA) at birth may be a consequence
of rapid early postnatal weight gain. Materials and methods: We pros- ...
Cited by 71 - Related articles - BL Direct - All 3 versions

Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying …

- diabetesjournals.org
M Ader, SP Kim, KJ Catalano, V Ionut, K … - Diabetes, 2005 - Am Diabetes Assoc
Atypical antipsychotics have been linked to weight gain, hyperglycemia, and
diabetes. We examined the effects of atypical antipsychotics olanzapine (OLZ)
and risperidone (RIS) versus placebo on adiposity, insulin sensitivity (S I ...
Cited by 64 - Related articles - All 7 versions

Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids


ME Cleasby, PAT Kelly, BR Walker, JR Seckl - Endocrinology, 2003 - Endocrine Soc
In utero overexposure to glucocorticoids may explain the association between low
birth weight and subsequent development of the metabolic syndrome. We previously
showed that prenatal dexamethasone (dex) exposure in the rat lowers birth ...
Cited by 55 - Related articles - BL Direct - All 5 versions

Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model


MD Jensen - Obesity, 2006 - nature.com
Results: Although visceral fat mass was positively correlated with adverse
health consequences and excess FFA availability, visceral fat was not the source
of excess systemic FFA availability. Upper body non-visceral fat ...
Cited by 52 - Related articles - BL Direct - All 4 versions

The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk


HN Ginsberg, AFH Stalenhoef - European Journal of Cardiovascular Prevention & …, 2003 - journals.lww.com
The metabolic syndrome is a complex constellation of disorders, each one a
significant risk factor for the development of cardiovascular disease (CVD). The
increasing prevalence of this condition is a major concern for healthcare ...
Cited by 55 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google